Combined and targeted drugs delivery system for colorectal cancer treatment: Conatumumab decorated, reactive oxygen species sensitive irinotecan prodrug and quercetin co-loaded nanostructured lipid carriers

PURPOSE: Colorectal cancer (CRC) is the third most frequently diagnosed cancer and this study aimed to develop a conatumumab decorated, irinotecan prodrug and quercetin co-loaded delivery system for combined and targeted colorectal cancer treatment. METHODS: A conatumumab (C) decorated, irinotecan p...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Youqiang, Zhang, Hongxin, Cui, Haijing, Zhang, Futong, Zhao, Liyan, Liu, Yibing, Meng, Qingju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786253/
https://www.ncbi.nlm.nih.gov/pubmed/35049388
http://dx.doi.org/10.1080/10717544.2022.2027573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786253/
https://www.ncbi.nlm.nih.gov/pubmed/35049388
http://dx.doi.org/10.1080/10717544.2022.2027573

Ejemplares similares